Related Experiment Videos
The β-reducing end in α(2-8)-polysialic acid constitutes a unique structural motif
Hugo F Azurmendi1, Marcos D Battistel1, Jasmin Zarb1
1Laboratory of Bacterial Polysaccharides, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20903, USA.
Glycobiology
|April 4, 2017
Summary
Structural studies of α(2-8)-polysialic acid reveal a unique β-anomeric configuration at the reducing end. This configuration forms a stabilizing hydrogen bond, influencing polymer structure and antibody binding.
Area of Science:
- Carbohydrate chemistry
- Structural biology
- Biophysics
Background:
- Structural characterization of α(2-8)-polysialic acid (polySia) in solution has been challenging.
- Previous studies focused on α-linked residues, neglecting terminal residue characteristics.
Purpose of the Study:
- To elucidate the structural and dynamic impact of the β-anomeric configuration at the reducing end of α(2-8)-polySia.
- To investigate the role of this terminal motif in polySia's interaction with antibodies.
Main Methods:
- Molecular dynamics (MD) simulations to predict hydrogen bond formation.
- Nuclear Magnetic Resonance (NMR) spectroscopy to detect the predicted hydrogen bond.
- Residual dipolar couplings and NOE-based distance measurements for structural analysis.
Main Results:
- A stable hydrogen bond was identified between the terminal β-anomeric hydroxyl group and the adjacent residue's carboxylate.
- This interaction defines a specific conformation with distinct hydration and charge patterns near the reducing end.
- The observed motif was found to be conserved in Sia oligosaccharides, impacting the structure of the first two residues of polySia.
Conclusions:
- The β-anomeric configuration at the reducing end of polySia creates a stable structural motif.
- This motif influences the overall structure and dynamics of α(2-8)-polysialic acid.
- The findings may explain the requirement of a specific polySia chain length for effective antibody binding.